ARCA biopharma Inc

NASDAQ:ABIO   3:31:29 PM EDT
3.14
+0.08 (+2.61%)
4:40:57 PM EDT: $3.17 +0.03 (+0.96%)
Products

Arca Biopharma Announces Submission Of Ind Application To U.S. FDA For Ab201 As A Potential Treatment For Covid-19

Published: 09/21/2020 12:38 GMT
ARCA biopharma Inc (ABIO) - Arca Biopharma Announces Submission of Ind Application to U.S. FDA for Ab201 As a Potential Treatment for Covid-19.
Arca Biopharma - Pending FDA Feedback, Anticipates Initiating Phase 2b Portion of Sequential Phase 2b/3 Clinical Evaluation of Ab201 As Early As Q4 of This Year.